Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The rationale for this trial is to apply a simple and minimally strenuous pre-screening approach prior to performing more extensive trial-specific screening and baseline-characterization activities in the resulting pre-selected population of subjects.
The pre-screening assessments are designed to characterize the metabolic risk profile / prediabetic status in an unselected population of overweight and obese volunteers, aiming to pre-select high risk and prediabetic subjects as a target population who may specifically profit from primary diabetes intervention (prevention) strategies.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Generally healthy | Generally healthy | ||
| Type 2 diabetes mellitus | Type 2 diabetes mellitus |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| anthropometric measures and metabolic biomarkers indicative of prediabetes | One blood sample taken on day 1 of the study | Day one |
| Measure | Description | Time Frame |
|---|---|---|
| intra-subject and inter-subject variability of analyzed biomarkers | Several circulating markers including the traditionally used fasting serum insulin and fasting plasma glucose as well as an oral glucose tolerance test may serve as indicators of prediabetes. Importantly, these parameters show considerable intra-individual short-term variability. The assessments will therefore be repeated three times within a one month period to determine intra-subject variability of the analyzed parameters under the conditions that apply to the trial site and experimental conditions. |
| Measure | Description | Time Frame |
|---|---|---|
| the correlation between anthropometric data, medical history, and biomarkers with regard to metabolic risk | assessment of study data at the end of the study | up to 3 years |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Generally healthy or Type 2 Diabetes mellitus
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Leona Plum-Mörschel, MD | Profil Institut für Stoffwechselforschung GmbH | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Profil Institut für Stoffwechselforschung GmbH | Neuss | 41460 | Germany |
Not provided
| ID | Term |
|---|---|
| D011236 | Prediabetic State |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood samples
| within one month |
| D004700 | Endocrine System Diseases |